Compare Abeona Therapeutics Inc (ABEO) vs AES Corp (AES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs AES Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while AES Corp trades at $14.7 (market cap $10.49B). The key difference: AES Corp is far larger — about 24.9× Abeona Therapeutics Inc's market cap, and AES Corp pays a 4.79% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | AES | |
|---|---|---|
Market Cap | $421.19M | $10.49B |
Sector | Health | Utilities |
52-Week High | $7.45 | $17.28 |
52-Week Low | $4.17 | $12.51 |
Enterprise Value | $276.10M | $40.75B |
Dividend Yield | — | 4.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About AES Corp
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →
